Golden Sparrow

VC unknown, United States · Founded 2023

Golden Sparrow is a US-domiciled venture fund that backs Indian-origin founders building Deep Tech and Enterprise AI for global markets. They focus on exceptional engineering talent in India and its diaspora, making fewer, deeper bets and staying involved for the long term.

About Golden Sparrow

Golden Sparrow is an early-stage venture firm with a generalist software thesis and a goldensparrow.vc website and LinkedIn and Twitter presence that does not surface explicit healthcare or AI sector focus, geography, or check size discipline. For healthcare AI founders, Golden Sparrow is a peripheral fund best understood as potential syndicate capital rather than a thesis-aligned lead investor. The public footprint is too thin for confident triage. Plausible check sizes for partnerships of this profile run 100K to 500K at seed and pre-seed, supporting rounds led by larger or more specialized firms. Founders building horizontal AI software with healthcare applications, or healthcare-flavored B2B SaaS with strong generalist software metrics, could open a conversation; the bar will be team and traction more than sector fit. Founders building regulated medtech, therapeutics, or clinical AI requiring deep healthcare networks should look at healthcare-native firms; the absence of public healthcare positioning signals limited domain depth. Entry path is LinkedIn direct outreach to partners with a tight pitch focused on team, market, and traction. Do not expect deep healthcare-specific diligence or sector value-add; expect a generalist read on standard B2B SaaS metrics. Realistic founder triage: this is a name to keep on a closing list once a thesis-aligned lead is committed, not a name to organize a round around. Spend warm-introduction budget on healthcare-specialist firms first, and only after a lead is locked should small generalist seed funds like Golden Sparrow be approached for syndicate participation. Treat any check from them as additive capital, and avoid handing them outsized board influence.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Golden Sparrow

Tools made by companies in Golden Sparrow's portfolio that we cover in the directory.

ClariCT.AI
ClariPi
Radiology & Imaging AI
ClariCT.AI is an FDA-cleared, AI-powered CT image denoising solution by ClariPi, enhancing clarity for low-dose and ultra-low-dose CT scans to improve diagnostic confidence and patient safety.
ClariSIGMAM
ClariPi
Oncology AI
ClariSIGMAM is an AI-powered breast density assessment solution by ClariPi that provides accurate and consistent density estimates from digital mammograms, aiding radiologists in breast tissue composition assessment and breast cancer risk prediction.
ClariPulmo
ClariPi
Oncology AI
ClariPulmo is a non-invasive image analysis software for use with CT images which is intended to support the quantification of lung CT images. The software is designed to support the physician in the diagnosis and documentation of pulmonary tissue images (e.g., abnormalities) from the CT thoracic datasets.

Portfolio companies in our directory

Other portfolio companies

Companies in Golden Sparrow's portfolio not currently in our directory.

Team

Rishaad Currimjee
General Partner
LinkedIn
Michael Marmor
Operating Partner - AI
LinkedIn
Ritik Singh
Principal
LinkedIn
Venkat Raju
Operating Partner - Deep Tech
LinkedIn
Dr. Amritendu Mukherjee
Venture Partner, Artificial Intelligence
LinkedIn
Dr. Anand Rao
Venture Partner, Artificial Intelligence
LinkedIn

Pitch / review this investor

Have you raised from Golden Sparrow? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.